<DOC>
	<DOCNO>NCT00685230</DOCNO>
	<brief_summary>There FDA approve therapy treatment scorpion envenomation , Centruroides scorpion envenomation produce pattern neurotoxicity spectrum severity range trivial life threaten . Patients stung Centruroides scorpion develop clinical syndrome may require sedation benzodiazepine observation 6 28 hour intensive care monitoring . A safe therapy necessary halt progression symptom early clinical course avoid clinical deterioration occur en route tertiary facility . Alacramyn速 anticipate safer effective present standard care , midazolam , faster-acting need transport rural patient eliminate reduce hospitalization time . The working hypothesis follow : 1 . The investigational antivenom safe treatment scorpion sting envenomation . 2 . The investigational antivenom effective treatment scorpion sting envenomation .</brief_summary>
	<brief_title>Double-Blind , Alacramyn速 v . Placebo Pediatric Patients</brief_title>
	<detailed_description>The purpose Prospective , Randomized , Double-Blind , Controlled , Multicenter Treatment Protocol , phase III trial examine safety efficacy Alacramyn速 treatment patient envenom scorpion sting . This study take place two pediatric Intensive care unit Tucson , Arizona . Patients arrive emergency clinic present scorpion sting symptom evaluate treatment respect inclusion/exclusion criterion accord study procedure . Only patient clinically important systemic sign scorpion sting envenomation include study . Baseline measure include severity evaluation scorpion sting envenomation . The patient 's vital sign , concomitant medication , medical history demographic data collect . Blood test do haematology , chemistry , venom anti-venom level urine test . After informed consent inclusion7exclusion criterion obtain verify , baseline measurement do , three vial Alacramyn速 placebo administer . During follow 3 hour , midazolam continue , indicate control agitation . Patients midazolam sedation receive study drug longer manifest clinically important systemic sign scorpion envenomation discharge 4 hour , 2 hour follow cessation midazolam drip , whichever occurs later . Prior discharge repeat lab work , physical assessment , vital sign do . Patients still require midazolam sedation and/or manifest clinically important systemic sign scorpion envenomation treat standard care duration clinical symptom . Those remain extended care undergo final study assessment time hospital discharge 24 hour study drug infusion hospitalization continue . All patient participate study contact 7 14 day treatment , look symptom suggestive ongoing venom effect , delay serum sickness well adverse event report patient .</detailed_description>
	<mesh_term>Bites Stings</mesh_term>
	<mesh_term>Poisoning</mesh_term>
	<mesh_term>Scorpion Stings</mesh_term>
	<mesh_term>Antivenins</mesh_term>
	<criteria>Males females 6 month 18 year age Presenting emergency treatment within 5 hour clinically important systemic sign scorpion sting envenomation . Signed write Informed Consent patient legal guardian . No participation clinical drug trial within last month concomitantly . Allergy horse serum . Use within past 24 hour drug expect alter immune response : H1 H2 blocker , corticosteroid . Use antivenom within last month concomitantly . Underlying medical condition significantly alter immune response : bone marrow suppression congenital acquire immunodeficiency state , chemotherapy chronic corticosteroid use . Allergy midazolam . More 0.3mg/kg body weight midazolam administer hour prior study drug infusion . Concurrent medical condition involve baseline neurologic status mimic envenomation ( chorea , tardive dyskinesia , uncontrolled epilepsy ) . Pregnant nursing woman .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>scorpion sting</keyword>
	<keyword>envenomation</keyword>
	<keyword>alacramyn</keyword>
</DOC>